Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 17, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Intellectual DisabilityDevelopmental DisabilityAggressionBehavior Problem

Interventions

DRUG

Nabilone

Nabilone capsules at a maximum dose of 1 mg twice a day

Trial Locations (1)

RECRUITING

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors

lead

Hsiang-Yuan Lin

OTHER